Atossa Therapeutics, Inc.
NASDAQ:ATOS
1.42 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -30.094 | -26.96 | -20.606 | -17.828 | -17.24 | -11.405 | -8.123 | -6.369 | -12.758 | -14.658 | -10.785 | -5.08 | -3.442 | -1.087 |
| Depreciation & Amortization
| 0.023 | 0.008 | 0.023 | 0.047 | 0.053 | 0.044 | 0.129 | 0.303 | 0.273 | 0.564 | 0.473 | 0.131 | 0.016 | 0 |
| Deferred Income Tax
| 1.077 | 0 | -5.622 | 2.364 | 0 | 0 | 0.76 | -0.713 | -3.474 | -0.489 | 0.663 | -0.092 | 3.534 | 0 |
| Stock Based Compensation
| 0.005 | 0.007 | 0.005 | 3.019 | 8.844 | 2.464 | 0.787 | 0.876 | 0.84 | 0.699 | 1.444 | 0.122 | 0.14 | 0.03 |
| Change In Working Capital
| 1.519 | -0.599 | -1.156 | -0.111 | -0.791 | -0.064 | -0.34 | -1.068 | 0.326 | 0.277 | -1.015 | 0.898 | -0.298 | 0.625 |
| Accounts Receivables
| 0.743 | 0.329 | -0.437 | 0.105 | -0.222 | -0.16 | -0.358 | 0 | 0.321 | -0.368 | -0.352 | -0.14 | -0.001 | 0 |
| Inventory
| 2.544 | -0.329 | 0.437 | -0.105 | 0.222 | 0 | 0 | 0 | 0.009 | -0.04 | -0.15 | -0.03 | -0.092 | 0 |
| Accounts Payables
| -2.159 | 1.248 | 0.128 | 1.295 | -0.06 | 0.018 | 0.081 | -0.56 | 0.301 | 0.346 | -0.059 | 0.003 | 0.065 | 0 |
| Other Working Capital
| 0.391 | -1.847 | -1.284 | -1.407 | -0.731 | -0.083 | -0.42 | -0.508 | -0.306 | 0.339 | -0.454 | 1.065 | -0.269 | 0.625 |
| Other Non Cash Items
| 6.529 | 0.003 | 5.622 | 0.939 | 0.006 | 2.693 | 0.193 | 1.595 | 0.84 | 3.051 | 0.39 | 0.122 | -3.442 | 0.073 |
| Operating Cash Flow
| -20.941 | -20.76 | -16.472 | -11.57 | -9.128 | -8.962 | -6.594 | -5.375 | -13.953 | -10.555 | -8.83 | -3.9 | -3.492 | -0.358 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -0.014 | -0.027 | -0.009 | -0.009 | -0.008 | -0.111 | 0 | -0.009 | -0.131 | -0.343 | -0.49 | -0.135 | -0.137 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.005 | -0.009 | -0.009 | -0.008 | -0.111 | 0 | -0.009 | -0.158 | -0 | -0 | -0.03 | 0 | 0 |
| Investing Cash Flow
| -0.014 | -4.727 | -0.009 | -0.009 | -0.008 | -0.111 | 0 | -0.009 | -0.288 | -0.343 | -0.49 | -0.135 | -0.137 | 0 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | -0.014 | 0 | 0 | 0 | 0 | 0 | -0.098 | 0 | -1.005 | -1 | 0 |
| Common Stock Issued
| 0 | 0 | 113.877 | 33.619 | 11.337 | 12.291 | 10.034 | 4.696 | 9.457 | 13.156 | 13.937 | 3.854 | 5.714 | 0.102 |
| Common Stock Repurchased
| -1.475 | 0 | -0.001 | -0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.675 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | -0.573 | 9.464 | 11.337 | 0.012 | 0.749 | 0.005 | 0.009 | 0.013 | 0.014 | -4.68 | 0.816 | 0.182 |
| Financing Cash Flow
| -1.475 | 0 | 113.304 | 38.552 | 11.337 | 12.291 | 10.783 | 4.696 | 9.457 | 13.057 | 13.937 | 3.849 | 5.53 | 0.284 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 22.408 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -22.43 | -25.487 | 96.823 | 26.973 | 2.201 | 3.218 | 4.19 | -0.688 | -4.785 | 2.159 | 4.617 | -0.186 | 1.901 | -0.074 |
| Cash At End Of Period
| 88.57 | 111 | 136.487 | 39.664 | 12.691 | 10.49 | 7.217 | 3.028 | 3.716 | 8.501 | 6.342 | 1.725 | 1.911 | 0.01 |